INHIBITORS OF JUN N-TERMINAL KINASE

The present disclosure provides inhibitors of c-Jun N-terminal kinases (JNK) having a structure according to the following formula (I): or a salt or solvate thereof, wherein ring A, Ca, Cb, Z, R5, W and Cy are defined herein. The disclosure fur-ther provides pharmaceutical compositions including the...

Full description

Saved in:
Bibliographic Details
Main Authors KONRADI, ANDREI W, NEITZ, R., JEFFREY, BOWERS, SIMEON, SEALY, JENNIFER, PROBST, GARY D, TOTH, GERGELY, HOM, ROY K, TRUONG, ANH, SHAM, HING L
Format Patent
LanguageEnglish
French
Published 09.01.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides inhibitors of c-Jun N-terminal kinases (JNK) having a structure according to the following formula (I): or a salt or solvate thereof, wherein ring A, Ca, Cb, Z, R5, W and Cy are defined herein. The disclosure fur-ther provides pharmaceutical compositions including the compounds of the present disclosure and methods of making and using the compounds and compositions of the present disclosure, e.g., in the treatment and prevention of various disorders, such as Alzheimer's disease. La présente invention concerne des inhibiteurs d'enzymes c-Jun N-terminal kinases (JNK) dotés d'une structure représentée par la formule suivante : ou un sel ou solvate de ceux-ci, où le cycle A, Ca, Cb, Z, R5, W et Cy sont définis dans la description. L'invention concerne également des compositions pharmaceutiques comprenant les composés de la présente invention et des procédés de préparation et d'utilisation des composés et compositions de la présente invention, par exemple dans le traitement et la prévention de diverses affections, telles que la maladie d'Alzheimer.
Bibliography:Application Number: CA20102751141